Alzheimer's drug approved in the UK, but it won't be available on the NHS—here's why
The UK's drugs regulator—the MHRA—has approved the Alzheimer's drug donanemab, but it won't be available on the NHS.
Oct 29, 2024
0
18
Amino Acids, Peptides, and Proteins: News and Research on Antibodies, Monoclonal
MeSH tree: D12.776.124.486.485.114.224
Treatments used for HER2-positive breast cancers could help patients with rare gastrointestinal cancer
Drugs designed to target HER2-postive breast cancer could also benefit some patients with bile duct cancer, according to results of a patient trial to be presented on Thursday at the 36th EORTC-NCI-AACR Symposium on Molecular ...
Oct 23, 2024
0
31
Bioengineered antibodies target mutant HER2 proteins
For some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between functioning normally and causing cancer. But despite causing major disease, these slightly mutated proteins ...
Oct 22, 2024
0
65
Immunotherapy boosts survival of advanced Hodgkin lymphoma in clinical trial
A treatment that rallies the immune system to destroy cancer raised the survival rate for advanced Hodgkin lymphoma patients to a remarkable 92%, suggesting a new standard therapy for the disease. The New England Journal ...
Oct 16, 2024
1
75
Exploring the current development and applications of monoclonal antibodies
A study led by Dr. Hassan Aboul-Ella (Department of Microbiology, Faculty of Veterinary Medicine, Cairo University) has been published in the journal Molecular Biomedicine.
Oct 16, 2024
0
45
A free drug experiment bypasses the US health system's secret fees
A top California health plan is set to offer one of the world's biggest-selling drugs for free in a bid to show the medicine can reach Americans affordably without going through the middlemen that typically control its flow.
Oct 7, 2024
0
22
Pharma company funding for patient advocacy groups needs to be transparent, says researcher
Patient groups should be playing a central role in Canada's health-care system, advocating for their members by promoting the visibility of their conditions, pushing for more rapid and accurate diagnoses and lobbying for ...
Oct 3, 2024
0
33
Why isn't the pharmaceutical industry using this alternative to horseshoe crab blood?
Since the 1960s when the bright-blue blood of horseshoe crabs was first discovered as a way to detect bacteria in vaccines and other injectables, millions of the ocean dwellers worldwide have been captured, their blood drained ...
Oct 2, 2024
0
34
2023 cisplatin shortage tied to use of alternatives for head, neck cancer
The 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presented at the American Society of Clinical ...
Oct 2, 2024
0
21
Researchers build first large-scale atlas of how immune cells react to mutations during cancer immunotherapy
A Cleveland Clinic-led research collaboration between Timothy Chan, MD, Ph.D., Chair of Cleveland Clinic's Global Center for Immunotherapy, and Bristol Myers Squibb has published the most comprehensive overview to date of ...
Oct 1, 2024
0
71
